Here are some things I think I am thinking about: 1. Floyd Mayweather – Maybe not such a financial disaster? Floyd Mayweather didn’t follow my financial advice. He was, predictably, MUCH better t...
The FDA on Wednesday opened a new era in cancer treatment, when it approved a landmark, futuristic new gene therapy-based approach to treat childhood leukemia, one which has produced unprecedented r...
Ok, so just a quick note on the euro. After blowing through 1.20 on Tuesday and getting some notable traction as a safe haven, the single currency has come off a bit on Wednesday, providing some welco...
The August reading of the “Euphoriameter” showed a small but noticeable move down from what was a more than 12-year high, certainly a post-financial-crisis high. As a reminder, the Euphori...
AstraZeneca PLC (AZN – Free Report) and Takeda Pharmaceutical Company Limited, a Japanese pharma company, have entered into an agreement to jointly develop and commercialize preclinical candi...
There’s been a lot of attention paid to the amount of equity that has been removed from the markets by corporate takeovers and buyback programs. Bloomberg recently put the number at about $5.5 trill...
It’s been well-documented here… Amazon (AMZN) is a serial killer, and its prey is retailers — ones who never thought of building a moat. Now, I’ll be the first to concede… In the old paradi...
Despite better than expected inflation and confidence data, the euro extended its losses today below 1.19. There’s some talk that the ECB could opt for a dovish taper next week to avoid driving the ...